Pegylated liposomal doxorubicin combined with ifosfamide for advanced soft tissue sarcomas: A phase I dose-escalation study

被引：0
|
作者：
Ye, Ting
Fan, Li
Cao, Rubo
Peng, Ling
Chen, Jing
机构：
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23525
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I study of non-pegylated liposomal doxorubicin in combination with ifosfamide in adult patients with metastatic soft tissue sarcomas
    Stroppa, Elisa
    Bertuzzi, Alexia
    Di Comite, Gabriele
    Mussi, Chiara
    Lutman, Romano Fabio
    Barbato, Alfredo
    Santoro, Armando
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (06) : 834 - 838
  • [2] Phase I study of non-pegylated liposomal doxorubicin in combination with ifosfamide in adult patients with metastatic soft tissue sarcomas
    Elisa Stroppa
    Alexia Bertuzzi
    Gabriele Di Comite
    Chiara Mussi
    Romano Fabio Lutman
    Alfredo Barbato
    Armando Santoro
    Investigational New Drugs, 2010, 28 : 834 - 838
  • [3] PHASE I STUDY OF NON-PEGYLATED LIPOSOMAL DOXORUBICIN IN COMBINATION WITH IFOSFAMIDE IN ADULT PATIENTS WITH METASTATIC SOFT TISSUE SARCOMAS
    Stroppa, Elisa
    Bertuzzi, Alexia
    Di Comite, Gabriele
    Salamina, Silvia
    Barbato, Alfredo
    Santoro, Armando
    ANNALS OF ONCOLOGY, 2009, 20
  • [4] A dose-escalation study of pegylated liposomal doxorubicin and oxaliplatin in patients with advanced solid tumors
    Kotsakis, A.
    Kouroussis, Ch.
    Androulakis, N.
    Agelaki, S.
    Kalbakis, K.
    Vamvakas, L.
    Vardakis, N.
    Kalykaki, A.
    Polyzos, A.
    Georgoulias, V.
    Mavroudis, D.
    ONCOLOGY, 2006, 71 (3-4) : 190 - 196
  • [5] Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
    Chawla, Sant P.
    Staddon, Arthur
    Hendifar, Andrew
    Messam, Conrad A.
    Patwardhan, Rita
    Kamel, Yasser Mostafa
    BMC CANCER, 2013, 13
  • [6] Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
    Sant P Chawla
    Arthur Staddon
    Andrew Hendifar
    Conrad A Messam
    Rita Patwardhan
    Yasser Yasser Mostafa Kamel
    BMC Cancer, 13
  • [7] Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx®) in combination with topotecan in patients with advanced malignancies
    Ghesquieres, Herve
    Faivre, Sandrine
    Djafari, Latifa
    Pautier, Patricia
    Lhomme, Catherine
    Lozahic, Stephanie
    Djazouli, Kamel
    Armand, Jean-Pierre
    Raymond, Eric
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (05) : 413 - 421
  • [8] Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas
    Leyvraz, S
    Bacchi, M
    Cerny, T
    Lissoni, A
    Sessa, C
    Bressoud, A
    Hermann, R
    ANNALS OF ONCOLOGY, 1998, 9 (08) : 877 - 884
  • [9] Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx®) in combination with topotecan in patients with advanced malignancies
    Hervé Ghesquières
    Sandrine Faivre
    Latifa Djafari
    Patricia Pautier
    Catherine Lhommé
    Stéphanie Lozahic
    Kamel Djazouli
    Jean-Pierre Armand
    Eric Raymond
    Investigational New Drugs, 2006, 24 : 413 - 421
  • [10] A phase I dose-escalation study of azacitidine in combination with temozolomide in patients with soft tissue sarcomas.
    Matushansky, I.
    Coakley, K. E.
    Uldrick, T. S.
    Taub, R. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345